Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's Lymphoma
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The aim of this trial is to determine the appropriate dose of pixantrone to be used in this
combination and obtain data on the combination's safety and activity profile.